# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | PD184352 (CI-1040) | 1 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
2. | Barasertib (AZD1152-HQPA) | 34 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
3. | Sorafenib | 5 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
4. | Nilotinib (AMN-107) | 38 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
5. | GW2580 (DMSO solution) | K00591a, Diaminopyrimidine1 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
6. | Canertinib (CI-1033) | 18 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
7. | AT7519 | 33 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
8. | Bosutinib Isomer 1, Free Base | 1 (SKI-606) | Kd | = | 4600 | nM | ALA1908721 | 5.34 | nM | Homo sapiens | ||
9. | GSK690693 | 3g, GSK-690693 | Kd | = | 990 | nM | ALA1908721 | 6.00 | nM | Homo sapiens | ||
10. | RAF265 (CHIR-265) | CHIR-265/RAF-265 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
11. | AST-487 (NVP-AST487) | AST-487 | Kd | = | 1500 | nM | ALA1908721 | 5.82 | nM | Homo sapiens | ||
12. | MLN8054 | MLN-8054 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
13. | GSK461364 | GSK-461364A | Kd | = | 1900 | nM | ALA1908721 | 5.72 | nM | Homo sapiens | ||
14. | ALA522892 | 5 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
15. | Motesanib | AMG-706 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
16. | SGX-523 | SGX-523 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
17. | Tandutinib (MLN518) | 75 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens | |||
18. | GSK1838705A | 40 | Kd | = | 410 | nM | ALA1908721 | 6.39 | nM | Homo sapiens | ||
19. | Lestaurtinib | CEP-701 | Kd | = | 8.9 | nM | ALA1908721 | 8.05 | nM | Homo sapiens | ||
20. | Axitinib | AG-13736 | Kd | > | 10000 | nM | ALA1908721 | nM | Homo sapiens |